Nagoya, Japan

Hitoshi Noda

This inventor holds 2 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Noda. Retrieved from https://idiyas.com/inventor/hitoshi-noda-3s5iwtum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Nagoya, JP (1996)
  • Aichi, JP (1996)

Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hitoshi Noda: Innovator in Polypeptide Research

Introduction

Hitoshi Noda is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of polypeptide research, particularly in the development of calcitonin analogues. With a total of 2 patents to his name, Noda's work has implications for various medical applications.

Latest Patents

Noda's latest patents include a polypeptide of calcitonin analogue and its use. This invention provides a polypeptide with an amino acid sequence where the proline-amide residue at the C-terminal of native eel calcitonin is substituted with a homoserine amide residue. Additionally, he has developed a modified polypeptide compound with VIP-like activity, represented by a specific general formula.

Career Highlights

Throughout his career, Noda has been associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has focused on innovative research in biochemistry and pharmacology. His work has contributed to advancements in therapeutic applications of polypeptides.

Collaborations

Noda has collaborated with notable colleagues such as Shigeaki Yoshina and Tsutomu Ishida, enhancing the scope and impact of his research through teamwork and shared expertise.

Conclusion

Hitoshi Noda's contributions to polypeptide research exemplify the importance of innovation in the medical field. His patents reflect a commitment to advancing scientific knowledge and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…